The selective inhibition of the Stat1 response to IL-6 we observed in early SLE could be due in part to moderate levels of SOCS1 that specifically target JAK2 activity while having relatively little influence on JAK1 (Fig. 4E). The gene discussed is IL6; the disease is systemic lupus erythematosus.